Meds and you

Updated 11 February 2013

Rabeprazole

Rabeprazole is prescribed to treat ulcers of the stomach and the first part of the small intestine that connects to the stomach, the duodenum.

0

Rabeprazole is the active ingredient of Pariet.

General Information

Rabeprazole is prescribed to treat ulcers of the stomach and the first part of the small intestine that connects to the stomach, the duodenum. It is also effective in treating gastro-oesophageal reflux, the backward flow of stomach acid contents into the oesophagus, the tube that connects the mouth to the stomach.

It is prescribed for longer periods of time to treat patients with Zollinger-Ellison syndrome, a rare condition associated with a tumour that creates high levels of stomach acid secretion.

In some cases rabeprazole is prescribed along with other medication - often two different antibiotics - to eradicate H. Pylori, a cause of stomach ulcers.

For this drug to remain effective, it has to be taken regularly; an ulcer may recur when you stop treatment prematurely.

Rabeprazole can mask the symptoms and may delay the diagnosis of stomach cancers -possible malignancy should be excluded prior to start of treatment.

How does rabeprazole work?

This medication decreases the production of acid in the stomach as a result of blocking an enzyme needed for acid manufacture.

Fast facts

Drug schedule: schedule 4

Available as: rabeprazole is available as tablets

What does it do ? rabeprazole reduces stomach acid production

Overdose risk : low

Dependence risk: low

Is rabeprazole available as a generic? no

Is rabeprazole available on prescription only? yes

User information

Onset of effect: within 3 hours

Duration of action: up to 24 hours

Dietary advice: rabeprazole should best be taken 30 minutes before a meal; Avoid food that may increase the production of stomach acid, such as alcohol, spicy meals, and so forth

Stopping this medicine: do not discontinue using this medication without consulting your doctor as symptoms may recur with premature discontinuation

Prolonged use: although few problems are expected, rabeprazole is not intended for indefinite use

Special precautions

Consult your doctor before using this drug if:

  • if you have a liver disease
  • if you are taking any other medication

Pregnancy: avoid. Potential risk to the foetus has been reported. Consult your doctor before use, or if you are planning to fall pregnant.

Breastfeeding: avoid. This medication is passed through breast milk and may affect your baby adversely. Consult your doctor before use.

Porphyria: avoid. This medication may cause serious adverse effects. Consult your doctor before use.

Infants and children: this medication is not intended for use in children and should only be prescribed by a paediatrician.

The elderly: no special precautions need to be taken.

Driving and hazardous work: caution is advised as use of this medication may lead to dizziness and/or light-headedness. Avoid such activities until you know how this medication affects you.

Alcohol: avoid concomitant use of alcohol with this medication as it may aggravate your condition and reduce the apparent efficacy of this medication.

Possible side effects:

Side effect

Frequency

Consult your doctor

Common

Rare

Only if severe

In all cases

diarrhoea

x

x

headache

x

x

nausea/ vomiting

x

x

abdominal pain

x

x

skin rash

x

x

jaundice

x

x

dizziness

X

x

Interactions:

Drug interactions:

digoxin

risk of digoxin toxicity

ketoconazole; itraconazole

reduced effect of these anti-fungal drugs

Disease interactions

Consult your doctor before using this drug if you have a liver disease.

Overdose action

A small overdose is no cause for concern. In case of intentional large overdose, seek emergency medical attention.

Recommended dosage

Adults: 10-20mg once daily.

This material is not intended to substitute medical advice, but is for informational purposes only. Please consult a physician for specific treatment and recommendations.

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.